Evidence map›Paper›PMID 40999035›Full record

ArticleVirchows Archiv : an international journal of pathology2025

An artificial intelligence model of whole-slide pathology specimens differentiating cutaneous high-grade squamous proliferations.

Anne Petzold, Anja Wessely, Michael Erdmann, Stefan Schliep, Stephan Schreml, Luis Carlos Rivera Monroy, Julio Vera, Konstantin Drexler, Dennis Niebel, Kinan Maurice Hayani and 4 more

Abstract read
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Vision transformer-based diagnosis of psoriasis and eczema in whole-slide histology.Virchows Archiv : an international journal of pathology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anne PetzoldDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Anja WesselyDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Michael ErdmannDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Stefan SchliepDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Stephan SchremlDepartment of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Luis Carlos Rivera MonroyPattern Recognition Lab, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91058, Erlangen, Germany.
Julio VeraDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Konstantin DrexlerDepartment of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Dennis NiebelDepartment of Dermatology, University Hospital Regensburg, Regensburg, Germany.
Kinan Maurice HayaniDepartment of Pathology, Wake Forest Baptist Health, Medical Center Boulevard, Winston-Salem, NC, USA.
Franklin KiesewetterMVZ Pathology, Sozialstiftung Bamberg, 96015, Bamberg, Germany.
Carola BerkingDepartment of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Elias A T Koch *Department of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Markus V Heppt *Department of Dermatology, Deutsches Zentrum Immuntherapie (DZI), CCC Erlangen-EMN, Bavarian Cancer Research Center (BZKF), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany. Markus.Heppt@uk-erlangen.de.ORCID http://orcid.org/0000-0003-4603-1825

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous squamous cell carcinoma (cSCC) and verruca vulgaris (VV) are skin conditions involving the proliferation of epidermal keratinocytes requiring fundamentally different treatments. Histological evaluation of highly differentiated squamous cell proliferations can be challenging, particularly in small or superficial samples. This study aims to improve diagnostic accuracy using an AI model to distinguish cSCC from VV. We developed a deep-learning model using clustering-constrained attention multiple instance learning (CLAM) to classify hematoxylin and eosin-stained whole-slide images (WSIs) as cSCC or VV. The dataset comprised 289 WSIs (n = 148 cSCC, n = 141 VV). Quality control was ensured through expert review: the training cohort was evaluated by four dermatopathologists, and the evaluation cohort by six additional experts. On the training set, the model achieved an AUROC of 0.99, with an accuracy of 94.9% for cSCC and 91.2% for VV. On the evaluation set, it reached an AUROC of 0.96, and accuracies of 82.4% (cSCC) and 97.4% (VV), similar to the average performance of individual dermatopathologists. We successfully trained and implemented an interpretable deep-learning-based weakly supervised model on WSIs distinguishing cSCC from VV, which could enhance AI-supported diagnostics in the future.

Indexed as

Cutaneous Squamous Cell CarcinomaDeep LearningImage Processing, Computer-AssistedSkin NeoplasmsWartsAgedAged, 80 and overCell ProliferationDatasets as TopicDiagnosis, DifferentialEosine Yellowish-(YS)FemaleHematoxylinHumansMaleMiddle AgedEosine Yellowish-(YS)HematoxylinArtificial IntelligenceCarcinoma, Squamous CellPathologyWarts

Identifiers

PMID40999035
PMCPMC12647221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.